ArticleNature communications2025

Anti-PD-L2 immunotherapy is efficacious against melanoma in aged hosts through IL-17 and IFNγ signalling.

Carlos O Ontiveros et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.